Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Theradex
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Utah
Center for International Blood and Marrow Transplant Research
Fred Hutchinson Cancer Center
Novartis
Montefiore Medical Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Taiho Oncology, Inc.
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
The University of Hong Kong
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Cogent Biosciences, Inc.
City of Hope Medical Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Imperial College London
Institute of Hematology & Blood Diseases Hospital, China
Heinrich-Heine University, Duesseldorf
Kura Oncology, Inc.
Kirby Institute
Rigshospitalet, Denmark
Fred Hutchinson Cancer Center
Universitätsklinikum Hamburg-Eppendorf
Asan Medical Center